Αποτελέσματα Αναζήτησης
26 Σεπ 2024 · WHO welcomes the latest findings from the PURPOSE-2 trial on long-acting injectable lenacapavir (LEN) for HIV prevention. An interim analysis, announced on 12 September 2024, demonstrated the drug’s remarkable efficacy in preventing HIV.
10 Ιουλ 2024 · GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention. The result “provides hope of accelerating efforts to end AIDS”, UNAIDS says, “but only if Gilead ensures that all people who need it can have access to this game-changing ...
26 Μαρ 2024 · A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV.
26 Ιουλ 2023 · The results of a novel study presented by Emory researchers during the International AIDS Society (IAS) Conference in Brisbane, Australia, have revealed exciting findings in the pursuit of an...
28 Νοε 2023 · According to the United Nations Programme on HIV/AIDS (UNAIDS), this would mean reaching the ‘95-95-95’ targets: at least 95% of people living with HIV should know their status; at least 95% of...
16 Ιουν 2023 · To test the potential of haplo-cord stem cell transplantation for HIV cure, the present observational study enrolled HIV-1-infected individuals who required allogeneic stem cell...
2 Σεπ 2024 · Longer-term solutions are in the works. But how close are we to a cure for HIV — or a vaccine? Nature spoke with specialists to find out. What advances have been made in the treatment of HIV?
